Minerva Neurosciences's total assets for Q3 2024 were $42.81M, a decrease of -7.51% from the previous quarter. NERV total liabilities were $64.48M for the fiscal quarter, a -28.97% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.